AHA - American Hospital Association
06/18/2026 | Press release | Distributed by Public on 06/18/2026 12:43
AHA Statement On Eli Lilly Withholding 340B Discounts
Rick Pollack
President and CEO
American Hospital Association
June 18, 2026
AHA can confirm that Eli Lilly has taken the extraordinary action of denying 340B discounts. Congress should immediately use its oversight authority and demand HHS take a position on drug companies' attempts to hijack the 340B program through burdensome claims-data demands. These manufacturer-imposed requirements would drain scarce resources from 340B hospitals and threaten patients' access to lifesaving drugs. HRSA and HHS cannot continue to stand by while Eli Lilly and others rewrite the rules for their own benefit and skirt their obligations.
###
AHA - American Hospital Association published this content on June 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 18, 2026 at 18:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]